Clinical and Preclinical Use of LOX-1-Specific Antibodies in Diagnostics and Therapeutics.

about

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

P2860

Q33564156-1DEE3DEA-2CE7-433F-8CFA-EFC49D5CFB9E

P2860

Clinical and Preclinical Use of LOX-1-Specific Antibodies in Diagnostics and Therapeutics.

Item

http://www.wikidata.org/entity/Q38589168

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical and Preclinical Use o ...... Diagnostics and Therapeutics.

@en

Clinical and Preclinical Use o ...... Diagnostics and Therapeutics.

@en-gb

type

Item

label

Clinical and Preclinical Use o ...... Diagnostics and Therapeutics.

@en

Clinical and Preclinical Use o ...... Diagnostics and Therapeutics.

@en-gb

prefLabel

Clinical and Preclinical Use o ...... Diagnostics and Therapeutics.

@en

Clinical and Preclinical Use o ...... Diagnostics and Therapeutics.

@en-gb

P1154

2-s2.0-84947488811

http://www.w3.org/2001/XMLSchema#string

P1433

Journal of Cardiovascular Translational Research

P1476

Clinical and Preclinical Use o ...... Diagnostics and Therapeutics.

@en

P2093

Izma Abdul Zani

http://www.w3.org/2001/XMLSchema#string

Jonathan De Siqueira

http://www.w3.org/2001/XMLSchema#string

Shervanthi Homer-Vanniasinkam

http://www.w3.org/2001/XMLSchema#string

Sreenivasan Ponnambalam

http://www.w3.org/2001/XMLSchema#string

P2860

An endothelial receptor for oxidized low-density lipoprotein

Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation

Role of LOX-1 and ROS in oxidized low-density lipoprotein induced epithelial-mesenchymal transition of NRK52E

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.

OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.

P2888

s12265-015-9655-z

P304

458-465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12265-015-9655-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sreenivasan Ponnambalam

Stephen Wheatcroft

David A Russell

P5530

6834221

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047584932

http://www.w3.org/2001/XMLSchema#string

P698

26385009

http://www.w3.org/2001/XMLSchema#string